ONCOLOGY INTELLIGENCE

Your oncology briefing

News, evidence & guideline updates distilled for rapid professional review.

Last source sync17 Sep 2026 · 14:34
RegulatoryPan-oncologyGeneral oncologyFDA Drug Updates

Ongoing | Cancer Accelerated Approvals

This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have postmarketing requirement(s) for ongoing clinical trial(s) to verify clinical benefit.

16 Sep 2026 · Source feed
RegulatoryPan-oncologyGeneral oncologyFDA Drug Updates

Verified Clinical Benefit | Cancer Accelerated Approvals

This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications with postmarketing trials that have verified clinical benefit and for which traditional approval has been subsequently granted for the specific indication.

16 Sep 2026 · Source feed